Orders for Merck & Co's oral antiviral for COVID-19 helped to swell the ... but even without the drug sales would have risen 19% thanks to a strong performance from cancer immunotherapy Keytruda ...

On the efficacy issue, Merck told ... develop severe COVID-19 than men. On the other hand, there were also more older people later on, which should have benefited the active drug.

New research showed some long COVID patients get symptom relief by taking an extended course of Paxlovid. Data are ...

Merck & Co.’s Covid-19 antivirals are getting a new lease of life in post-pandemic China, as cat owners seize on them as antidotes to a life-threatening disease caused by a coronavirus that ...

Discover how scientists developed a COVID-19 vaccine in record time using mRNA technology, leading to improved public health ...

Merck shares trade at a significant discount to peers. The company faces challenges, but there are reasons to be bullish.

Merck & Co's Covid-19 antivirals are getting a new lease ... response to Bloomberg News that the company hasn't tested the drug on cats and has no plans to do so. Chinese pet owner's use of ...